Peloton announced today that it’s launching its first 12-week Hyrox Training Program to help members prepare for the race.
Pfizer Inc. and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced positive results from the Phase 3 EV-304 clinical trial (also known as KEYNOTE-B15) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results